Synthetic lethal RNAi screening for the identification of genes that modulate cisplatin and paclitaxel response in human ovarian cancer cells

被引:0
|
作者
Arora, Shilpi [1 ]
Peralta, Lourdes [1 ]
Bisanz, Kristen [1 ]
Choudhary, Ashish [1 ]
Azorsa, David [1 ]
机构
[1] Translat Genom Res Inst, Scottsdale, AZ USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2582
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Profiling essential genes in human mammary cells by multiplex RNAi screening
    Silva, Jose M.
    Marran, Krista
    Parker, Joel S.
    Silva, Javier
    Golding, Michael
    Schlabach, Michael R.
    Elledge, Stephen J.
    Hannon, Gregory J.
    Chang, Kenneth
    SCIENCE, 2008, 319 (5863) : 617 - 620
  • [32] Cisplatin, carboplatin and irradiation in human ovarian cancer cells
    DePooter, CH
    Scalliet, P
    VanOosterom, AT
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 826 - 826
  • [33] Stroma cells modulate growth and response to therapy in ovarian cancer cells
    Liu, J.
    Yao, M.
    Kryczck, I.
    Kuick, R.
    Fogoros, S.
    Opipari, A.
    Kwok, R.
    Bowtell, D. D.
    Zou, W.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S153 - S153
  • [34] Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity
    Gamarra-Luques, Carlos D.
    Hapon, Maria B.
    Goyeneche, Alicia A.
    Telleria, Carlos M.
    JOURNAL OF OVARIAN RESEARCH, 2014, 7
  • [35] Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity
    Carlos D Gamarra-Luques
    Maria B Hapon
    Alicia A Goyeneche
    Carlos M Telleria
    Journal of Ovarian Research, 7
  • [36] Identification of cancer-specific synthetic lethal genes as novel therapeutic targets
    Nunga, Lalchung
    Schwalbe, Ed
    Lafta, Fadhel
    Tweddle, Deborah
    Maris, John
    Barrow, Timothy
    Strathdee, Gordon
    CANCER RESEARCH, 2020, 80 (16)
  • [37] Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer
    A. Marijne Heeren
    Iske F. van Luijk
    Joost Lakeman
    Noëlle Pocorni
    Jeroen Kole
    Renée X. de Menezes
    Gemma G. Kenter
    Tjalling Bosse
    Cornelis D. de Kroon
    Ekaterina S. Jordanova
    Cancer Immunology, Immunotherapy, 2019, 68 : 1759 - 1767
  • [38] Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer
    Heeren, A. Marijne
    van Luijk, Iske F.
    Lakeman, Joost
    Pocorni, Noelle
    Kole, Jeroen
    de Menezes, Renee X.
    Kenter, Gem Ma G.
    Bosse, Tjalling
    de Kroon, Cornelis D.
    Jordanova, Ekaterina S.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (11) : 1759 - 1767
  • [39] Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells
    Levasseur, LM
    Greco, WR
    Rustum, YM
    Slocum, HK
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (06) : 495 - 505
  • [40] Acetaminophen enhances the chemotherapeutic effect of cisplatin and paclitaxel on human ovarian carcinoma cells in vitro
    Wu, Jeffrey J.
    Neuwelt, Alexander J.
    Muldoon, Leslie L.
    Neuwelt, Edward A.
    CANCER RESEARCH, 2012, 72